MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation

被引:274
作者
Fujita, N
Jaye, DL
Geigerman, C
Akyildiz, A
Mooney, MR
Boss, JM
Wade, PA [1 ]
机构
[1] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Div Hematopathol, Atlanta, GA 30322 USA
[3] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA
[4] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
关键词
D O I
10.1016/j.cell.2004.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/ NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.
引用
收藏
页码:75 / 86
页数:12
相关论文
共 54 条
  • [1] CD20 POSITIVE HUMAN LYMPHOCYTES-B SEPARATED WITH THE MAGNETIC CELL SORTER (MACS) CAN BE INDUCED TO PROLIFERATION AND ANTIBODY SECRETION INVITRO
    ABTS, H
    EMMERICH, M
    MILTENYI, S
    RADBRUCH, A
    TESCH, H
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1989, 125 (1-2) : 19 - 28
  • [3] Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain
    Ahmad, KF
    Melnick, A
    Lax, S
    Bouchard, D
    Liu, J
    Kiang, CL
    Mayer, S
    Takahashi, S
    Licht, JD
    Privé, GG
    [J]. MOLECULAR CELL, 2003, 12 (06) : 1551 - 1564
  • [4] Acetylation inactivates the transcriptional repressor BCL6
    Bereshchenko, OR
    Gu, W
    Dalla-Favera, R
    [J]. NATURE GENETICS, 2002, 32 (04) : 606 - 613
  • [5] Antigen-specific B-lymphocyte activation
    Bishop, GA
    Haxhinasto, SA
    Stunz, LL
    Hostager, BS
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 2003, 23 (03) : 149 - 197
  • [6] Transcriptional regulation of the MHC class II antigen presentation pathway
    Boss, JM
    Jensen, PE
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) : 105 - 111
  • [7] Mi-2/NuRD: multiple complexes for many purposes
    Bowen, NJ
    Fujita, N
    Kajita, M
    Wade, PA
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2004, 1677 (1-3): : 52 - 57
  • [8] Regulatory mechanisms that determine the development and function of plasma cells
    Calame, KL
    Lin, KI
    Tunyaplin, C
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2003, 21 : 205 - 230
  • [9] Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells
    Coffee, B
    Zhang, FP
    Warren, ST
    Reines, D
    [J]. NATURE GENETICS, 1999, 22 (01) : 98 - 101
  • [10] Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein
    Dhordain, P
    Albagli, O
    Lin, RJ
    Ansieau, S
    Quief, S
    Leutz, A
    Kerckaert, JP
    Evans, RM
    Leprince, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (20) : 10762 - 10767